世界の転移性骨疾患の治療市場：市場規模・現状・予測

• 英文タイトル：Global Medication Treatment of Metastatic Bone Disease Market Size, Status and Forecast 2019-2025

• レポートコード：QYR9N7531
• 出版社/出版日：QYResearch / 2019年6月14日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、93ページ
• 納品方法：Eメール（受注後２～3営業日）
• 産業分類：医療・製薬・バイオ

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当資料は、転移性骨疾患の治療のグローバル市場について調査・分析したレポートで、種類別（）、用途別（）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・転移性骨疾患の治療の世界市場規模
・主要企業別市場シェア
・転移性骨疾患の治療の世界市場規模：種類別（）
・転移性骨疾患の治療の世界市場規模：用途別（）
・転移性骨疾患の治療のアメリカ市場規模（種類別、用途別）
・転移性骨疾患の治療のヨーロッパ市場規模（種類別、用途別）
・転移性骨疾患の治療の中国市場規模（種類別、用途別）
・転移性骨疾患の治療の日本市場規模（種類別、用途別）
・転移性骨疾患の治療の東南アジア市場規模（種類別、用途別）
・転移性骨疾患の治療のインド市場規模（種類別、用途別）
・転移性骨疾患の治療の中南米市場規模（種類別、用途別）
・主要企業別分析（企業概要、製品動向、販売量など）
・転移性骨疾患の治療の世界市場予測（2019年-2025年）
・転移性骨疾患の治療の地域別市場予測（2019年-2025年）
...

Metastatic bone disease can be quite agonizing to patients, both emotionally and financially, when they discover that their cancer has reached an advanced stage, thereby diminishing their chance of survival and adding to the treatment costs. In 2018, the global Medication Treatment of Metastatic Bone Disease market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Medication Treatment of Metastatic Bone Disease status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Medication Treatment of Metastatic Bone Disease development in United States, Europe and China.

The key players covered in this study
Amgen
Merck & Co
Roche
Novartis
Eli Lilly and Company
Bayer
Fresenius Kabi
BTG plc
Boston Scientific
Medtronic

Market segment by Type, the product can be split into
Chemotherapy
Hormone Therapy
Bisphosphonates
Opiate Therapy
Immunotherapy

Market segment by Application, split into
Hospitals
Clinics
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Medication Treatment of Metastatic Bone Disease status, future forecast, growth opportunity, key market and key players.
To present the Medication Treatment of Metastatic Bone Disease development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Medication Treatment of Metastatic Bone Disease are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Medication Treatment of Metastatic Bone Disease Market Size Growth Rate by Type (2014-2025)
1.4.2 Chemotherapy
1.4.3 Hormone Therapy
1.4.4 Bisphosphonates
1.4.5 Opiate Therapy
1.4.6 Immunotherapy
1.5 Market by Application
1.5.1 Global Medication Treatment of Metastatic Bone Disease Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Medication Treatment of Metastatic Bone Disease Market Size
2.2 Medication Treatment of Metastatic Bone Disease Growth Trends by Regions
2.2.1 Medication Treatment of Metastatic Bone Disease Market Size by Regions (2014-2025)
2.2.2 Medication Treatment of Metastatic Bone Disease Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Medication Treatment of Metastatic Bone Disease Market Size by Manufacturers
3.1.1 Global Medication Treatment of Metastatic Bone Disease Revenue by Manufacturers (2014-2019)
3.1.2 Global Medication Treatment of Metastatic Bone Disease Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Medication Treatment of Metastatic Bone Disease Market Concentration Ratio (CR5 and HHI)
3.2 Medication Treatment of Metastatic Bone Disease Key Players Head office and Area Served
3.3 Key Players Medication Treatment of Metastatic Bone Disease Product/Solution/Service
3.4 Date of Enter into Medication Treatment of Metastatic Bone Disease Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Medication Treatment of Metastatic Bone Disease Market Size by Type (2014-2019)
4.2 Global Medication Treatment of Metastatic Bone Disease Market Size by Application (2014-2019)

5 United States
5.1 United States Medication Treatment of Metastatic Bone Disease Market Size (2014-2019)
5.2 Medication Treatment of Metastatic Bone Disease Key Players in United States
5.3 United States Medication Treatment of Metastatic Bone Disease Market Size by Type
5.4 United States Medication Treatment of Metastatic Bone Disease Market Size by Application

6 Europe
6.1 Europe Medication Treatment of Metastatic Bone Disease Market Size (2014-2019)
6.2 Medication Treatment of Metastatic Bone Disease Key Players in Europe
6.3 Europe Medication Treatment of Metastatic Bone Disease Market Size by Type
6.4 Europe Medication Treatment of Metastatic Bone Disease Market Size by Application

7 China
7.1 China Medication Treatment of Metastatic Bone Disease Market Size (2014-2019)
7.2 Medication Treatment of Metastatic Bone Disease Key Players in China
7.3 China Medication Treatment of Metastatic Bone Disease Market Size by Type
7.4 China Medication Treatment of Metastatic Bone Disease Market Size by Application

8 Japan
8.1 Japan Medication Treatment of Metastatic Bone Disease Market Size (2014-2019)
8.2 Medication Treatment of Metastatic Bone Disease Key Players in Japan
8.3 Japan Medication Treatment of Metastatic Bone Disease Market Size by Type
8.4 Japan Medication Treatment of Metastatic Bone Disease Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Medication Treatment of Metastatic Bone Disease Market Size (2014-2019)
9.2 Medication Treatment of Metastatic Bone Disease Key Players in Southeast Asia
9.3 Southeast Asia Medication Treatment of Metastatic Bone Disease Market Size by Type
9.4 Southeast Asia Medication Treatment of Metastatic Bone Disease Market Size by Application

10 India
10.1 India Medication Treatment of Metastatic Bone Disease Market Size (2014-2019)
10.2 Medication Treatment of Metastatic Bone Disease Key Players in India
10.3 India Medication Treatment of Metastatic Bone Disease Market Size by Type
10.4 India Medication Treatment of Metastatic Bone Disease Market Size by Application

11 Central & South America
11.1 Central & South America Medication Treatment of Metastatic Bone Disease Market Size (2014-2019)
11.2 Medication Treatment of Metastatic Bone Disease Key Players in Central & South America
11.3 Central & South America Medication Treatment of Metastatic Bone Disease Market Size by Type
11.4 Central & South America Medication Treatment of Metastatic Bone Disease Market Size by Application

12 International Players Profiles
12.1 Amgen
12.1.1 Amgen Company Details
12.1.2 Company Description and Business Overview
12.1.3 Medication Treatment of Metastatic Bone Disease Introduction
12.1.4 Amgen Revenue in Medication Treatment of Metastatic Bone Disease Business (2014-2019)
12.1.5 Amgen Recent Development
12.2 Merck & Co
12.2.1 Merck & Co Company Details
12.2.2 Company Description and Business Overview
12.2.3 Medication Treatment of Metastatic Bone Disease Introduction
12.2.4 Merck & Co Revenue in Medication Treatment of Metastatic Bone Disease Business (2014-2019)
12.2.5 Merck & Co Recent Development
12.3 Roche
12.3.1 Roche Company Details
12.3.2 Company Description and Business Overview
12.3.3 Medication Treatment of Metastatic Bone Disease Introduction
12.3.4 Roche Revenue in Medication Treatment of Metastatic Bone Disease Business (2014-2019)
12.3.5 Roche Recent Development
12.4 Novartis
12.4.1 Novartis Company Details
12.4.2 Company Description and Business Overview
12.4.3 Medication Treatment of Metastatic Bone Disease Introduction
12.4.4 Novartis Revenue in Medication Treatment of Metastatic Bone Disease Business (2014-2019)
12.4.5 Novartis Recent Development
12.5 Eli Lilly and Company
12.5.1 Eli Lilly and Company Company Details
12.5.2 Company Description and Business Overview
12.5.3 Medication Treatment of Metastatic Bone Disease Introduction
12.5.4 Eli Lilly and Company Revenue in Medication Treatment of Metastatic Bone Disease Business (2014-2019)
12.5.5 Eli Lilly and Company Recent Development
12.6 Bayer
12.6.1 Bayer Company Details
12.6.2 Company Description and Business Overview
12.6.3 Medication Treatment of Metastatic Bone Disease Introduction
12.6.4 Bayer Revenue in Medication Treatment of Metastatic Bone Disease Business (2014-2019)
12.6.5 Bayer Recent Development
12.7 Fresenius Kabi
12.7.1 Fresenius Kabi Company Details
12.7.2 Company Description and Business Overview
12.7.3 Medication Treatment of Metastatic Bone Disease Introduction
12.7.4 Fresenius Kabi Revenue in Medication Treatment of Metastatic Bone Disease Business (2014-2019)
12.7.5 Fresenius Kabi Recent Development
12.8 BTG plc
12.8.1 BTG plc Company Details
12.8.2 Company Description and Business Overview
12.8.3 Medication Treatment of Metastatic Bone Disease Introduction
12.8.4 BTG plc Revenue in Medication Treatment of Metastatic Bone Disease Business (2014-2019)
12.8.5 BTG plc Recent Development
12.9 Boston Scientific
12.9.1 Boston Scientific Company Details
12.9.2 Company Description and Business Overview
12.9.3 Medication Treatment of Metastatic Bone Disease Introduction
12.9.4 Boston Scientific Revenue in Medication Treatment of Metastatic Bone Disease Business (2014-2019)
12.9.5 Boston Scientific Recent Development
12.10 Medtronic
12.10.1 Medtronic Company Details
12.10.2 Company Description and Business Overview
12.10.3 Medication Treatment of Metastatic Bone Disease Introduction
12.10.4 Medtronic Revenue in Medication Treatment of Metastatic Bone Disease Business (2014-2019)
12.10.5 Medtronic Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Medication Treatment of Metastatic Bone Disease Key Market Segments
Table Key Players Medication Treatment of Metastatic Bone Disease Covered
Table Global Medication Treatment of Metastatic Bone Disease Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Medication Treatment of Metastatic Bone Disease Market Size Market Share by Type 2014-2025
Figure Chemotherapy Figures
Table Key Players of Chemotherapy
Figure Hormone Therapy Figures
Table Key Players of Hormone Therapy
Figure Bisphosphonates Figures
Table Key Players of Bisphosphonates
Figure Opiate Therapy Figures
Table Key Players of Opiate Therapy
Figure Immunotherapy Figures
Table Key Players of Immunotherapy
Table Global Medication Treatment of Metastatic Bone Disease Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Others Case Studies
Figure Medication Treatment of Metastatic Bone Disease Report Years Considered
Table Global Medication Treatment of Metastatic Bone Disease Market Size 2014-2025 (Million US$)
Figure Global Medication Treatment of Metastatic Bone Disease Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Medication Treatment of Metastatic Bone Disease Market Size by Regions 2014-2025 (Million US$)
Table Global Medication Treatment of Metastatic Bone Disease Market Size by Regions 2014-2019 (Million US$)
Table Global Medication Treatment of Metastatic Bone Disease Market Share by Regions 2014-2019
Figure Global Medication Treatment of Metastatic Bone Disease Market Share by Regions 2014-2019
Figure Global Medication Treatment of Metastatic Bone Disease Market Share by Regions 2019
Table Market Top Trends
Table Global Medication Treatment of Metastatic Bone Disease Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Medication Treatment of Metastatic Bone Disease Market Share by Manufacturers (2014-2019)
Figure Global Medication Treatment of Metastatic Bone Disease Market Share by Manufacturers in 2018
Table Global Medication Treatment of Metastatic Bone Disease Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Medication Treatment of Metastatic Bone Disease Product/Solution/Service
Table Date of Enter into Medication Treatment of Metastatic Bone Disease Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Medication Treatment of Metastatic Bone Disease Market Size by Type (2014-2019) (Million US$)
Table Global Medication Treatment of Metastatic Bone Disease Market Size Share by Type (2014-2019)
Figure Global Medication Treatment of Metastatic Bone Disease Market Size Market Share by Type (2014-2019)
Table Global Medication Treatment of Metastatic Bone Disease Market Size by Application (2014-2019) (Million US$)
Table Global Medication Treatment of Metastatic Bone Disease Market Size Share by Application (2014-2019)
Figure Global Medication Treatment of Metastatic Bone Disease Market Size Market Share by Application (2014-2019)
Figure Global Medication Treatment of Metastatic Bone Disease Revenue Market Share by Application in 2018
Figure United States Medication Treatment of Metastatic Bone Disease Market Size 2014-2019 (Million US$)
Table United States Key Players Medication Treatment of Metastatic Bone Disease Revenue (2018-2019) (Million US$)
Table United States Key Players Medication Treatment of Metastatic Bone Disease Market Share (2018-2019)
Table United States Medication Treatment of Metastatic Bone Disease Market Size by Type (2014-2019) (Million US$)
Table United States Medication Treatment of Metastatic Bone Disease Market Share by Type (2014-2019)
Table United States Medication Treatment of Metastatic Bone Disease Market Size by Application (2014-2019) (Million US$)
Table United States Medication Treatment of Metastatic Bone Disease Market Share by Application (2014-2019)
Figure Europe Medication Treatment of Metastatic Bone Disease Market Size 2014-2019 (Million US$)
Table Europe Key Players Medication Treatment of Metastatic Bone Disease Revenue (2018-2019) (Million US$)
Table Europe Key Players Medication Treatment of Metastatic Bone Disease Market Share (2018-2019)
Table Europe Medication Treatment of Metastatic Bone Disease Market Size by Type (2014-2019) (Million US$)
Table Europe Medication Treatment of Metastatic Bone Disease Market Share by Type (2014-2019)
Table Europe Medication Treatment of Metastatic Bone Disease Market Size by Application (2014-2019) (Million US$)
Table Europe Medication Treatment of Metastatic Bone Disease Market Share by Application (2014-2019)
Figure China Medication Treatment of Metastatic Bone Disease Market Size 2014-2019 (Million US$)
Table China Key Players Medication Treatment of Metastatic Bone Disease Revenue (2018-2019) (Million US$)
Table China Key Players Medication Treatment of Metastatic Bone Disease Market Share (2018-2019)
Table China Medication Treatment of Metastatic Bone Disease Market Size by Type (2014-20189) (Million US$)
Table China Medication Treatment of Metastatic Bone Disease Market Share by Type (2014-2019)
Table China Medication Treatment of Metastatic Bone Disease Market Size by Application (2014-2019) (Million US$)
Table China Medication Treatment of Metastatic Bone Disease Market Share by Application (2014-2019)
Figure Japan Medication Treatment of Metastatic Bone Disease Market Size 2014-2019 (Million US$)
Table Japan Key Players Medication Treatment of Metastatic Bone Disease Revenue (2018-2019) (Million US$)
Table Japan Key Players Medication Treatment of Metastatic Bone Disease Market Share (2018-2019)
Table Japan Medication Treatment of Metastatic Bone Disease Market Size by Type (2014-2019) (Million US$)
Table Japan Medication Treatment of Metastatic Bone Disease Market Share by Type (2014-2019)
Table Japan Medication Treatment of Metastatic Bone Disease Market Size by Application (2014-2019) (Million US$)
Table Japan Medication Treatment of Metastatic Bone Disease Market Share by Application (2014-2019)
Figure Southeast Asia Medication Treatment of Metastatic Bone Disease Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Medication Treatment of Metastatic Bone Disease Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Medication Treatment of Metastatic Bone Disease Market Share (2018-2019)
Table Southeast Asia Medication Treatment of Metastatic Bone Disease Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Medication Treatment of Metastatic Bone Disease Market Share by Type (2014-2019)
Table Southeast Asia Medication Treatment of Metastatic Bone Disease Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Medication Treatment of Metastatic Bone Disease Market Share by Application (2014-2019)
Figure India Medication Treatment of Metastatic Bone Disease Market Size 2014-2019 (Million US$)
Table India Key Players Medication Treatment of Metastatic Bone Disease Revenue (2018-2019) (Million US$)
Table India Key Players Medication Treatment of Metastatic Bone Disease Market Share (2018-2019)
Table India Medication Treatment of Metastatic Bone Disease Market Size by Type (2014-2019) (Million US$)
Table India Medication Treatment of Metastatic Bone Disease Market Share by Type (2014-2019)
Table India Medication Treatment of Metastatic Bone Disease Market Size by Application (2014-2019) (Million US$)
Table India Medication Treatment of Metastatic Bone Disease Market Share by Application (2014-2019)
Figure Central & South America Medication Treatment of Metastatic Bone Disease Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Medication Treatment of Metastatic Bone Disease Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Medication Treatment of Metastatic Bone Disease Market Share (2018-2019)
Table Central & South America Medication Treatment of Metastatic Bone Disease Market Size by Type (2014-2019) (Million US$)
Table Central & South America Medication Treatment of Metastatic Bone Disease Market Share by Type (2014-2019)
Table Central & South America Medication Treatment of Metastatic Bone Disease Market Size by Application (2014-2019) (Million US$)
Table Central & South America Medication Treatment of Metastatic Bone Disease Market Share by Application (2014-2019)
Table Amgen Company Details
Table Amgen Revenue in Medication Treatment of Metastatic Bone Disease Business (2014-2019) (Million US$)
Figure Amgen Revenue Growth Rate in Medication Treatment of Metastatic Bone Disease Business (2014-2019)
Table Amgen Recent Development
Table Merck & Co Company Details
Table Merck & Co Revenue in Medication Treatment of Metastatic Bone Disease Business (2014-2019)(Million US$)
Figure Merck & Co Revenue Growth Rate in Medication Treatment of Metastatic Bone Disease Business (2014-2019)
Table Merck & Co Recent Development
Table Roche Company Details
Table Roche Revenue in Medication Treatment of Metastatic Bone Disease Business (2014-2019)(Million US$)
Figure Roche Revenue Growth Rate in Medication Treatment of Metastatic Bone Disease Business (2014-2019)
Table Roche Recent Development
Table Novartis Company Details
Table Novartis Revenue in Medication Treatment of Metastatic Bone Disease Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Medication Treatment of Metastatic Bone Disease Business (2014-2019)
Table Novartis Recent Development
Table Eli Lilly and Company Company Details
Table Eli Lilly and Company Revenue in Medication Treatment of Metastatic Bone Disease Business (2014-2019)(Million US$)
Figure Eli Lilly and Company Revenue Growth Rate in Medication Treatment of Metastatic Bone Disease Business (2014-2019)
Table Eli Lilly and Company Recent Development
Table Bayer Company Details
Table Bayer Revenue in Medication Treatment of Metastatic Bone Disease Business (2014-2019)(Million US$)
Figure Bayer Revenue Growth Rate in Medication Treatment of Metastatic Bone Disease Business (2014-2019)
Table Bayer Recent Development
Table Fresenius Kabi Company Details
Table Fresenius Kabi Revenue in Medication Treatment of Metastatic Bone Disease Business (2014-2019)(Million US$)
Figure Fresenius Kabi Revenue Growth Rate in Medication Treatment of Metastatic Bone Disease Business (2014-2019)
Table Fresenius Kabi Recent Development
Table BTG plc Company Details
Table BTG plc Revenue in Medication Treatment of Metastatic Bone Disease Business (2014-2019)(Million US$)
Figure BTG plc Revenue Growth Rate in Medication Treatment of Metastatic Bone Disease Business (2014-2019)
Table BTG plc Recent Development
Table Boston Scientific Company Details
Table Boston Scientific Revenue in Medication Treatment of Metastatic Bone Disease Business (2014-2019)(Million US$)
Figure Boston Scientific Revenue Growth Rate in Medication Treatment of Metastatic Bone Disease Business (2014-2019)
Table Boston Scientific Recent Development
Table Medtronic Company Details
Table Medtronic Revenue in Medication Treatment of Metastatic Bone Disease Business (2014-2019)(Million US$)
Figure Medtronic Revenue Growth Rate in Medication Treatment of Metastatic Bone Disease Business (2014-2019)
Table Medtronic Recent Development
Table Global Medication Treatment of Metastatic Bone Disease Market Size by Regions (Million US$) 2019-2025
Figure Global Medication Treatment of Metastatic Bone Disease Market Size Share by Regions (2019-2025)
Figure Global Medication Treatment of Metastatic Bone Disease Market Size Share by Regions in 2025
Figure United States Medication Treatment of Metastatic Bone Disease Market Size Forecast (2019-2025)(Million USD)
Figure Europe Medication Treatment of Metastatic Bone Disease Market Size Forecast (2019-2025)(Million USD)
Figure China Medication Treatment of Metastatic Bone Disease Market Size Forecast (2019-2025)(Million USD)
Figure Japan Medication Treatment of Metastatic Bone Disease Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Medication Treatment of Metastatic Bone Disease Market Size Forecast (2019-2025)(Million USD)
Figure India Medication Treatment of Metastatic Bone Disease Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Medication Treatment of Metastatic Bone Disease Market Size Forecast (2019-2025)(Million USD)
Table Global Medication Treatment of Metastatic Bone Disease Market Size by Product (2019-2025) (Million US$)
Figure Global Medication Treatment of Metastatic Bone Disease Market Size by Product (2019-2025)
Figure Global Medication Treatment of Metastatic Bone Disease Market Size by Product in 2025
Table Global Medication Treatment of Metastatic Bone Disease Market Size by Application (2019-2025) (Million US$)
Figure Global Medication Treatment of Metastatic Bone Disease Market Size by Application (2019-2025)
Figure Global Medication Treatment of Metastatic Bone Disease Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介

世界の転移性骨疾患市場：市場規模・現状・予測

Global Metastatic Bone Disease Market Size, Status and Forecast 2019-2025
QYR9N7550 2019年6月14日 96Pages
当資料は、転移性骨疾患のグローバル市場について調査・分析したレポートで、種類別（）、用途別（）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・転移性骨疾患の世界市場規模
・主...

世界の転移性骨がんの薬物治療市場：市場規模・現状・予測

Global Metastatic Bones Cancer Medication Treatment Market Size, Status and Forecast 2019-2025
QYR9N7552 2019年6月14日 95Pages
当資料は、転移性骨がんの薬物治療のグローバル市場について調査・分析したレポートで、種類別（）、用途別（）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・転移性骨がんの薬物治療の世界市場規...

世界の消失性骨疾患市場：市場規模・現状・予測

Global Vanishing Bone Disease Market Size, Status and Forecast 2019-2025
QYR9N8166 2019年6月14日 92Pages
当資料は、消失性骨疾患のグローバル市場について調査・分析したレポートで、種類別（医学療法、放射線療法）、用途別（病院、診療所、診断センター、外来手術センター）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

世界の転移性乳がんの治療市場：市場規模・現状・予測

Global Metastatic Breast Cancer Treatment Market Size, Status and Forecast 2019-2025
QYR9N7553 2019年6月14日 96Pages
当資料は、転移性乳がんの治療のグローバル市場について調査・分析したレポートで、種類別（化学療法、放射線療法、生物学的標的療法、乳房手術、ホルモン療法）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含...

世界の転移性大腸がんの治療市場：市場規模・現状・予測

Global Metastatic Colorectal Cancer Treatment Market Size, Status and Forecast 2019-2025
QYR9N7555 2019年6月14日 95Pages
当資料は、転移性大腸がんの治療のグローバル市場について調査・分析したレポートで、種類別（手術、化学療法）、用途別（病院、診療所、がん研究センター）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

世界のRefsum病治療市場：市場規模・現状・予測

Global Refsum Disease Treatment Market Size, Status and Forecast 2019-2025
QYR9N7944 2019年6月14日 90Pages
当資料は、Refsum病治療のグローバル市場について調査・分析したレポートで、種類別（手術療法、薬）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・Ref...

世界のメニエール病治療市場：市場規模・現状・予測

Global Meniere's Disease Treatment Market Size, Status and Forecast 2019-2025
QYR9N7539 2019年6月14日 92Pages
当資料は、メニエール病治療のグローバル市場について調査・分析したレポートで、種類別（薬、非侵襲的治療法と手順、中耳への注射、手術、その他）、用途別（病院、診療所、医学研究センター、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報な...

世界のフォンヴィレブランド病治療市場：市場規模・現状・予測

Global Von Willebrand Disease Treatment Market Size, Status and Forecast 2019-2025
QYR9N8188 2019年6月14日 93Pages
当資料は、フォンヴィレブランド病治療のグローバル市場について調査・分析したレポートで、種類別（ヴェイヴォンディ、フミン酸-P、英数字、その他）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれてい...

世界の転移性骨がん市場：市場規模・現状・予測

Global Metastatic Bones Cancer Market Size, Status and Forecast 2019-2025
QYR9N7551 2019年6月14日 94Pages
当資料は、転移性骨がんのグローバル市場について調査・分析したレポートで、種類別（）、用途別（）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・転移性骨がんの世界市場規模
・主...

世界のクッシング病治療市場：市場規模・現状・予測

Global Cushing’s Disease Treatment Market Size, Status and Forecast 2019-2025
QYR9N7048 2019年6月14日 94Pages
当資料は、クッシング病治療のグローバル市場について調査・分析したレポートで、種類別（ケトコナゾール、ミトタン、アミノグルテチミド、メチラポン、ミフェプリストン、その他）、用途別（病院薬局、小売薬局、ドラッグストア、診療所、Eコマース/オンライン薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東...

世界の転移性骨がんの薬物治療市場：市場規模・現状・予測 Bone metastasis occurs when cancer cells spread from their original site to a bone. Nearly all types ofcancer can spread (metastasize) to the bones. But some types of cancer are particularly likely to spread to bone, including breast cancer and prostatecancerIn 2018, the global Metastatic Bones Canc…
世界の転移性骨疾患市場：市場規模・現状・予測 Metastatic bone disease can be quite agonizing to patients, both emotionally and financially, when they discover that their cancer has reached an advanced stage, thereby diminishing their chance of survival and adding to the treatment costs. In 2018, the global Metastatic Bone Disease market size wa…
世界の転移性乳がんの治療市場：市場規模・現状・予測 Metastatic breast cancer is an advanced stage of breast cancer. It involves cases in which breast cancer has spread to the other parts of the body. Some of the most common organs which are affected by metastatic breast cancer are brain, liver, bones and lungs. It is also known as stage IV breast can…
世界の消失性骨疾患市場：市場規模・現状・予測 Vanishing bone disease or Gorham-stout syndrome is a rare skeletal disease characterized by progressive osteolysis and the proliferation of lymphatic vessels within the bone which leads to the destruction and absorption of bone. Additionally, the bones affected by the disease are more prone to osteo…
世界の転移性大腸がんの治療市場：市場規模・現状・予測 Colorectal cancer is the third most common type cancer and represents 9.7% of total cancer cases across the globe. According to American Cancer Society colorectal cancer is treatable and curable when it is localized to the bowel. However, colorectal cancer cancers that have spread to other body part…